PARSIPPANY, NJ, Oct 03, 2011 (MARKETWIRE via COMTEX) -- The Medicines Company (MDCO) announced today launch of a new twelve hour formulation for Cleviprex(R) (clevidipine) Injectable Emulsion, which ...
PARSIPPANY, N.J. & FOSTER CITY, Calif.--(BUSINESS WIRE)--The Medicines Company (Nasdaq:MDCO), a global biopharmaceutical company focused on hospital care, and SciClone Pharmaceuticals (Nasdaq: SCLN), ...
The Medicines Company today announced that the U.S. Food and Drug Administration has accepted the Parsippany-based pharmaceutical company’s new drug application for Cleviprex for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results